Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. Sabahaddin Akman, owner of the Turkish firm Ozay Pharmaceuticals, pleaded guilty in the U.S. District Court for the Eastern District of Missouri, to smuggling counterfeit cancer drugs including multiple shipments of Altuzan, the Turkish version of bevacizumab (Avastin, Genentech).
The drugs did not meet FDA standards and had not been approved for distribution in the United States. The FDA’s Office of Criminal Investigations organized an international investigation that led to Akman’s arrest in Puerto Rico in January 2014. The investigation identified Akman and his company as a source of Altuzan.
Related Posts
RongKluea raids net another B10m in fake goods 5 Mar 2016
Authorities have seized another 10 million baht worth of counterfeit brand-name...
Is your anti-counterfeiting strategy up to scratch?
Counterfeit activity is a threat to all modern businesses, affecting their...
Greece Ranks 2nd in Counterfeit and Contraband Consumption in EU
Greece continues to have the 2nd highest rate of C&C (Counterfeit and...
1,590 e-cigarettes seized at KIA
Bengaluru Air Customs stated in a release that the smuggling attempt was foiled...